These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6298424)

  • 61. Relationships between structure and vascular activity in a series of benzylisoquinolines.
    Chulia S; Ivorra MD; Martinez S; Elorriaga M; Valiente M; Noguera MA; Lugnier C; Advenier C; D'Ocon P
    Br J Pharmacol; 1997 Oct; 122(3):409-16. PubMed ID: 9351495
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of inhibitors of cyclic nucleotide phosphodiesterases on electrical and contractile activity of smooth muscle cells.
    Kovalev IV; Popov AG; Baskakov MB; Minochenko IL; Kilin AA; Borodin YL; Anfinogenova YD; Kapilevich LV; Medvedev MA
    Bull Exp Biol Med; 2002 Jan; 133(1):38-40. PubMed ID: 12170302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases.
    Helfman DM; Kuo JF
    Biochem Pharmacol; 1982 Jan; 31(1):43-7. PubMed ID: 6277336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
    Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
    [No Abstract]   [Full Text] [Related]  

  • 67. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
    Reynolds CH; Claxton PT
    Biochem Pharmacol; 1982 Feb; 31(3):419-21. PubMed ID: 6280730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of carbenoxolone on phosphodiesterase and prostaglandin synthetase activities.
    Vapaatalo H; Lindén IB; Metsä-Ketelä T; Kangasaho M; Laustiola K
    Experientia; 1978 Mar; 34(3):384-5. PubMed ID: 204509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
    Manganiello V
    Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
    [No Abstract]   [Full Text] [Related]  

  • 71. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 72. HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.
    Ruppert D; Weithmann KU
    Life Sci; 1982 Nov; 31(19):2037-43. PubMed ID: 6294426
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins.
    Nichols MR; Morimoto BH
    Mol Pharmacol; 2000 Apr; 57(4):738-45. PubMed ID: 10727520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of 3-isobutyl-1-methylxanthine and zaprinast on non-adrenergic non-cholinergic relaxation in the rat gastric fundus.
    Barbier AJ; Lefebvre RA
    Eur J Pharmacol; 1992 Jan; 210(3):315-23. PubMed ID: 1377130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PDE inhibitors: a new approach to treat metabolic syndrome?
    Lugnier C
    Curr Opin Pharmacol; 2011 Dec; 11(6):698-706. PubMed ID: 22018840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studies on griseolic acid derivatives. III. Synthesis and biological activities of the adducts of griseolic acid and their base exchanged derivatives.
    Murofushi Y; Kimura M; Kuwano H; Iijima Y; Yamazaki M; Kaneko M
    Nucleic Acids Symp Ser; 1986; (17):45-8. PubMed ID: 3031627
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activity.
    Booth RF; Lunt DO; Lad N; Buckham SP; Oswald S; Clough DP; Floyd CD; Dickens J
    Biochem Pharmacol; 1990 Nov; 40(10):2315-21. PubMed ID: 2173927
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.